# Surveillance of Pancreatic Health After Diabetes Diagnosis

Study · id `cardio:ct-nct06803771` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06803771](<https://clinicaltrials.gov/study/NCT06803771>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06803771

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.

## Technical summary

Registry record NCT06803771. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-05-21 (actual); primary completion 2029-07-29 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 5000 participants (planned count; ClinicalTrials.gov record NCT06803771, source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)
- Started: 2025-05-21 (actual) (ClinicalTrials.gov record NCT06803771, source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)
- Primary completion: 2029-07-29 (anticipated) (ClinicalTrials.gov record NCT06803771, source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)
- Completion: 2032-07 (anticipated) (ClinicalTrials.gov record NCT06803771, source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT06803771, source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06803771-2026-09-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Surveillance of Pancreatic Health After Diabetes Diagnosis
- Acronym: SAFE-D
- Condition: Diabetes Mellitus
- Condition: Pancreatic Cancer, Adult
- Intervention (Device): Avantect Pancreatic Cancer Test
- Lead sponsor: University Hospital Southampton NHS Foundation Trust
- Lead sponsor class: OTHER
- Collaborator: ClearNote Health
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University Hospital Southampton NHS Foundation Trust (`cardio:org-university-hospital-southampton-nhs-foundation-trust`)

## Provenance

Content hash: 25998921cc7a1fd8f779cb862942daa7673a7843aebc1a8acab105ffeaac8fde
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
